Related Experiment Videos

Differences in antibiotic prescribing patterns for children younger than five years in the three major outpatient

Natasha B Halasa1, Marie R Griffin, Yuwei Zhu

  • 1Department of Pediatrics, Vanderbilt University School of Medicine, Nashville, Tennessee 37232, USA.

The Journal of Pediatrics
|February 5, 2004
PubMed

Insights

Antibiotic prescribing for young children declined between 1994-2000, particularly in office-based and emergency department settings. This trend indicates a positive shift in antibiotic stewardship for pediatric outpatient care.

Area of Science:

  • Pediatric infectious disease
  • Antimicrobial stewardship
  • Public health surveillance

Background:

  • Antibiotic overuse is a significant public health concern, contributing to antimicrobial resistance.
  • Understanding prescribing patterns in different outpatient settings is crucial for targeted interventions.

Purpose of the Study:

  • To analyze antibiotic utilization across three major outpatient settings: office-based clinics, emergency departments (ED), and hospital-based clinics.
  • To examine trends in antibiotic prescribing for children under 5 years of age from 1994 to 2000.

Main Methods:

  • Utilized data from the National Ambulatory Medical Care Survey (NAMCS) and National Hospital Ambulatory Medical Care Survey (NHAMCS).
  • Analyzed visit rates and antibiotic prescribing patterns for children <5 years of age.
  • Compared prescribing practices across office-based clinics, EDs, and hospital-based clinics.

Main Results:

  • Overall antibiotic prescription rates decreased from 1405 to 1088 per 1000 children.
  • Significant declines were observed in office-based settings (1119 to 841) and EDs (237 to 198).
  • Racial disparities in antibiotic receipt were noted, though prescribing rates became similar for white and black children later in the study period.

Conclusions:

  • A notable decline in antibiotic prescribing for children under 5 years old occurred.
  • This decline was most pronounced in office-based and emergency department settings.
  • Findings highlight evolving antibiotic stewardship practices in pediatric outpatient care.
Abstract

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
Factors Affecting Drug Response: Overview01:21

Factors Affecting Drug Response: Overview

When it comes to infants and young children, they are typically administered smaller doses of medication in comparison to adults. This is primarily because their organ functions still need to fully develop, meaning their bodies are not as efficient at metabolizing or eliminating drugs. Additionally, their blood-brain barrier is more permeable than in adults. As a result, high concentrations of drugs can easily penetrate the central nervous system (CNS), potentially leading to neurological...